ATAI News and Press, ATAI Life Sciences N.V. From 07/15/23

2023-07-15 04:25:01 ET Summary The memo reads that the bear market has been cancelled, and there are few who are as happy about the change in fortunes as Cathie Wood and ARK Funds. Her flagship ARKK fund, as well as other ARK family funds, have had an impressive run lately and wer...

2023-07-14 19:10:45 ET Summary A review of recent research suggests that the testing methods may have led to overly optimistic expectations. A competitive drug has been approved and appears to be making excellent commercial headway. COMPASS Pathways is short on cash but has ma...

A recent study has found that psilocybin-assisted group psychotherapy can help alleviate the mental woes of cancer patients with depression. While several treatments are designed to kill cancer cells and alleviate the physical symptoms caused by cancer, the mental distress associated with a can...

2023-07-13 12:35:00 ET Summary Will tough times continue for psychedelic stocks? Analyst Alex Carchidi shares his views on the sector and specific stocks like Compass Pathways, Atai and Cybin. Inevitability of big pharma entering the space. Listen below or on the g...

As America has become increasingly progressive in its drug policy, psychedelics have turned from relatively obscure drugs enjoyed by a niche community to potentially game-changing mental-health treatments. Studies on hallucinogenic drugs such as psilocybin (magic mushrooms), MDMA and ayahuasca ...

A recent psychedelic study has indicated that hallucinogens such as psilocybin may be able to unlock the critical “learning period ” when mammals are more susceptible to their outside environment. This is a period of brain development when mammals can engage with their surroundings...

Previous research has discovered that psilocybin can effectively treat substance-use disorders. Now, a new study has provided new insights into how psilocybin-assisted therapy works for individuals who are addicted to alcohol. For their study, scientists at UC San Francisco, NYU and Fluence...

Psychedelics are currently experiencing a renaissance that could leave them at the top of the psychiatric industry. Over the past couple of years, research has shown that natural and synthetic psychedelics show potential to treat symptoms of various mental health conditions. Although treatmen...

2023-06-05 08:50:32 ET Forza X1 ( FRZA ) +133% . Timber Pharmaceuticals ( TMBR ) +92% Announces FDA Grant of CARC Waiver for TMB-001 Chijet Motor Company ( CJET ) +55% . CIRCOR International ( CIR ) +50% to be bought by KKR in $1.6B deal. ...

SEATTLE, June 01, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative proprietary medicines to address significant unmet needs in oncology with a current focus on breast cancer, today announces the appointment of Greg...